Steve Ubl, the head of the powerful pharmaceutical lobbying group PhRMA, is set to depart from his position by the end of the year. Ubl has been with PhRMA for over a decade, during which he has become one of Washington’s most influential drug industry lobbyists. A search for his successor is already underway as the organization prepares for this transition.